Abstract:Proteins have proven to be useful agents in a variety of fields, from serving as potent therapeutics to enabling complex catalysis for chemical manufacture. However, they remain difficult to design and are instead typically selected for using extensive screens or directed evolution. Recent developments in protein large language models have enabled fast generation of diverse protein sequences in unexplored regions of protein space predicted to fold into varied structures, bind relevant targets, and catalyze novel reactions. Nevertheless, we lack methods to characterize these proteins experimentally at scale and update generative models based on those results. We describe Protein CREATE (Computational Redesign via an Experiment-Augmented Training Engine), an integrated computational and experimental pipeline that incorporates an experimental workflow leveraging next generation sequencing and phage display with single-molecule readouts to collect vast amounts of quantitative binding data for updating protein large language models. We use Protein CREATE to generate and assay thousands of designed binders to IL-7 receptor α and insulin receptor with parallel positive and negative selections to identify on-target binders. We discover not only individual novel binders but also features of ligand-receptor binding, including preservation of the IL7Rα - ligand hydrophobic interface specifically and existence of multiple approaches to contact the insulin receptor. We also demonstrate the importance of structural features, such as the lack of unpaired cysteine residues, toward design fidelity and find computational pre-screening metrics, such as interchain predicted TM scoring (iPTM), while useful, are imperfect predictors as they neither guarantee experimental binding nor rule it out. We use the data collected from Protein CREATE to score designs from the initial generative models. Globally, Protein CREATE will power future closed-loop design-build-test cycles to enable fine-grained design of protein binders.

Mapping targetable sites on the human surfaceome for the design of novel binders

De novo design of protein interactions with learned surface fingerprints

Design of High Affinity Binders to Convex Protein Target Sites

BindCraft: one-shot design of functional protein binders

Targeting protein-ligand neosurfaces using a generalizable deep learning approach

Improved protein binder design using ꞵ-pairing targeted RFdiffusion

Robust de novo design of protein binding proteins from target structural information alone

De Novo Design of Peptide Binders to Conformationally Diverse Targets with Contrastive Language Modeling

De novo design of high-affinity protein binders with AlphaProteo

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

De novo design of high-affinity binders of bioactive helical peptides

Design of Peptide Binders to Conformationally Diverse Targets with Contrastive Language Modeling

Design of high specificity binders for peptide-MHC-I complexes

Protein CREATE enables closed-loop design of de novo synthetic protein binders

Peptide binder design with inverse folding and protein structure prediction

Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations

Identification of Cavities on Protein Surface Using Multiple Computational Approaches for Drug Binding Site Prediction

PepMLM: Target Sequence-Conditioned Generation of Therapeutic Peptide Binders via Span Masked Language Modeling

AutoMatch: Target-Binding Protein Design and Enzyme Design by Automatic Pinpointing Potential Active Sites in Available Protein Scaffolds.

Cell surface thermal proteome profiling tracks perturbations and drug targets on the plasma membrane

Accurate de novo design of high-affinity protein binding macrocycles using deep learning